Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament composition for treating leukoderma

A composition and vitiligo technology, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of high recurrence rate, unsatisfactory cure rate, cost of several hundred to thousands of yuan, etc., to achieve quick and remarkable effect , low cost effect

Inactive Publication Date: 2009-06-24
牛付立
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, Chinese and Western medicine at home and abroad have no definite conclusions on its etiology and pathogenesis. Therefore, the treatment and medication are all explorations. Up to now, there is no drug and therapy with certain curative effect, and the cure rate is not ideal.
[0003] At present, the treatment of vitiligo generally uses autologous blistering, epidermal transplantation and psoralen long-wave ultraviolet irradiation (PVVA) therapy. The cost of one treatment costs several hundred yuan to thousands of yuan, and the recurrence rate is high, which brings great mental pain to the family. and financial burden

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] A pharmaceutical composition for treating vitiligo, which is made of the following raw materials in parts by weight: 10 safflower, 50 pangolin, 500 leech, 20 psoralen, 10 eclipse, 60 fig, 40 moutan bark, 60 cnidium, Tribulus Terrestris 60, Polygonum Polygoni Multiflori 60 and Black Sesame 60. When preparing the medicine, the impurities in the above-mentioned medicine raw materials are removed, and the raw medicines are mixed and pulverized through a 120-mesh sieve.

Embodiment 2

[0035] A pharmaceutical composition for treating vitiligo, which is made of the following raw materials in parts by weight: 40 parts by weight of safflower, 150 parts by pangolin, 150 parts by leech, 100 parts by psoralen, 300 parts by eclipse, 300 parts by fig, 200 parts by moutan bark, 300 parts by cnidium, Tribulus Terrestris 300, Polygonum Polygoni Multiflori 300 and Black Sesame 300. When preparing the medicine, the impurities in the above-mentioned medicine raw materials are removed, and the raw medicines are mixed and pulverized through a 200-mesh sieve.

Embodiment 3

[0037] A pharmaceutical composition for treating vitiligo, which is made of the following raw materials in parts by weight: 30 parts by weight of safflower, 120 parts of pangolin, 100 parts of leech, 20 parts of psoralen, 200 parts of Eclipta, 150 parts of fig, 40 parts of Moutan bark, 100 parts of Cnidium chinensis, Tribulus Terrestris 60, Polygonum Polygoni Multiflori 180 and Black Sesame 60. When preparing the medicine, the impurities in the above-mentioned medicine raw materials are removed, and the raw medicines are mixed and pulverized through a 180-mesh sieve.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for treating vitiligo, which belongs to orally administrative traditional Chinese medicine preparation. The medicine composition for treating vitiligo is prepared from the following raw materials by weight portion: 10 to 40 portions of safflower, 50 to 150 portions of pangolins, 50 to 150 portions of leeches, 20 to 100 portions of psoralea corylifolia, 10 to 300 portions of eclipta alba, 60 to 300 portions of ficus carica, 40 to 200 portions of tree peony barks, 60 to 300 portions of frutus cnidii, 60 to 300 portions of tribulus terrestris, 60 to 300 portions of fallopia multiflora and 60 to 300 portions of oriental sesame seeds. The safflower, the pangolins and the leeches selected by the invention are main medicines and have the functions of activating blood circulation and dissipating blood stasis; the frutus cnidii, the psoralea corylifolia, the eclipta alba, the fallopia multiflora and the oriental sesame seeds are auxiliary medicines and have the function of regulating viscera; and ficus carica, the tree peony barks and the tribulus terrestris are adjuvant medicines and cooperate with other medicines. The medicine composition can effectively relieve phrenalgia of patients and lighten economic burden of the patients, and has definite treatment effect, and the disease can not recur after being cured.

Description

Technical field: [0001] The invention relates to an oral Chinese medicinal preparation, in particular to a medicinal composition for treating local skin vitiligo caused by local qi and blood imbalance. Background technique: [0002] Vitiligo (vitiligo) is a common multiple pigmented skin disease, which is characterized by partial or generalized depigmentation and the formation of white spots. It is an acquired, localized or generalized skin depigmentation disease. It is a common skin disease, but also a kind of refractory stubborn disease. So far, there is no definite conclusion on its etiology and pathogenesis by Chinese and Western medicine both at home and abroad, so the treatment and medication are all explorations. Up to now, there is no medicine and therapy with a certain curative effect, and the cure rate is not ideal. [0003] At present, the treatment of vitiligo generally uses autologous blistering, epidermal transplantation and psoralen long-wave ultraviolet irra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/71A61P17/00A61K35/36A61K35/62
Inventor 牛付立
Owner 牛付立
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products